Astrid A.M. van der Veldt
Erasmus MC(NL)University Medical Center(US)Erasmus MC Cancer Institute(NL)Erasmus University Rotterdam(NL)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, CAR-T cell therapy research, Immunotherapy and Immune Responses
Most-Cited Works
- → Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma(2022)495 cited
- → Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs(2012)333 cited
- → Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial(2022)332 cited
- → Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective(2020)191 cited
- → Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1–Treated Patients in the Dutch Melanoma Treatment Registry(2020)177 cited
- → Sunitinib for Treatment of Advanced Renal Cell Cancer: Primary Tumor Response(2008)170 cited